Identity
- Trade Name
- Evera™ S VR FDA UDI
- Generic Name
- Single-chamber implantable defibrillator FDA UDI
- Device Name
- ICD-VR DVBC3D4 EVERA S US DF4 FDA UDI
- Model / Reference
- DVBC3D4 FDA UDI
- Description
- ICD-VR DVBC3D4 EVERA S US DF4 FDA UDI
Identifiers
- Primary DI / UDI-DI
- 00643169929876 FDA UDI
- FDA Product Code
- LWS FDA UDI
- GMDN Term
- Single-chamber implantable defibrillator FDA UDI
Classification
- Device Class
- Class III FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
Yes
FDA UDI
Single Use
Yes
FDA UDI
Implantable
Yes
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
No
FDA UDI
Serial Number
Yes
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Single-chamber implantable defibrillator
Evera™ S VR by Medtronic, Inc. — Class III — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Single-chamber implantable defibrillator.
- Fortify Assura™ — ST. JUDE MEDICAL, INC. · Class III
- Ellipse™ — ST. JUDE MEDICAL, INC. · Class III
- Rivacor 5 VR-T DF4 ProMRI — BIOTRONIK SE & Co. KG · Class III
- DYNAGEN™ EL ICD VR — Boston Scientific · Class III
- Gallant™ — ST. JUDE MEDICAL, INC. · Class III
- Paradym RF — MICROPORT CRM SRL · Class III
- FORTIFY™ — ST. JUDE MEDICAL, INC. · Class III
- Intica 7 VR-T DX DF-1 ProMRI — BIOTRONIK SE & Co. KG · Class III
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class III | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Medtronic, Inc.
Sources (1)
- FDA UDI 20becf6f-5efc-44cf-b576-bab31901fb02 35 fields · synced May 30, 2026